Success at Phase 3 for acne cream

Following on from good Phase 2 trials (see here) Israel’s Sol-Gel reported excellent results from pivotal Phase 3 clinical trials of its Twyneo treatment of patients with acne vulgaris. The trial significantly reduced moderate-to-severe acne in 858 patients aged nine and older.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *